Earth Science Tech (ETST) Cash from Financing Activities (2011 - 2025)
Earth Science Tech (ETST) reported Cash from Financing Activities of -$190608.0 for Q4 2025, down 199.33% on a YoY basis from $191894.0 in Q4 2024, and up 9.86% quarter-over-quarter from -$211459.0 in Q3 2025.
Earth Science Tech (ETST) Cash from Financing Activities (2011 - 2025) Analysis & Trends
Earth Science Tech has reported Cash from Financing Activities for 14 years, with the latest figure at -$190608.0 in Q4 2025.
- For the quarter ending Q4 2025, Cash from Financing Activities fell 199.33% year-over-year to -$190608.0; the trailing twelve-month figure through Dec 2025 stood at -$1.6 million (down 46.1% YoY), and the FY2025 full-year result was -$1.7 million, down 231.26% from the prior year.
- Cash from Financing Activities for Q4 2025 stood at -$190608.0, up from -$211459.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was $350068.0 in Q1 2023, with the low at -$972595.0 in Q1 2025.
- Historically, Cash from Financing Activities has averaged -$87660.9 across 5 years, with a median of $10000.0 in 2021.
- Annual changes were most pronounced in 2022 — Cash from Financing Activities surged 3065.0% — and 2024, when it sank 795.24%.
- Earth Science Tech's Cash from Financing Activities stood at $10000.0 in 2021, then surged by 3065.0% to $316500.0 in 2022, then slumped by 150.96% to -$161302.0 in 2023, then jumped by 218.97% to $191894.0 in 2024, then slumped by 199.33% to -$190608.0 in 2025.
- The last three Cash from Financing Activities figures came in at -$190608.0 (Q4 2025), -$211459.0 (Q3 2025), and -$266803.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 13.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -840.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -1.48 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -86.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -65.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.47 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -77.88 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -11.62 Mn |
| 10 | Earth Science Tech | - | - | 6.40 Mn | -190,608.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -190,608.00 |
| Dec 31, 2025 | -190,608.00 |
| Sep 30, 2025 | -211,459.00 |
| Sep 30, 2025 | -211,459.00 |
| Jun 30, 2025 | -266,803.00 |
| Jun 30, 2025 | -266,803.00 |
| Mar 31, 2025 | -972,595.00 |
| Mar 31, 2025 | -972,595.00 |
| Dec 31, 2024 | 191,894.00 |
| Dec 31, 2024 | 191,894.00 |
| Sep 30, 2024 | -770,058.00 |
| Sep 30, 2024 | -770,058.00 |
| Jun 30, 2024 | -164,774.00 |
| Jun 30, 2024 | -164,774.00 |
| Mar 31, 2024 | -380,568.00 |
| Mar 31, 2024 | -380,568.00 |
| Dec 31, 2023 | -161,302.00 |
| Dec 31, 2023 | -161,302.00 |
| Sep 30, 2023 | -86,017.00 |
| Sep 30, 2023 | -86,017.00 |